PD06-11 INTRAVESICAL BOTULINUM TOXIN A INJECTIONS IN PATIENTS ON ANTIPLATELET AND ANTICOAGULATION THERAPY

INTRODUCTION AND OBJECTIVES:Intravesical OnabotulinumToxin-A(Botox) injections are an established treatment for idiopathic and neurogenic detrusor overactivity (IDO and NDO). The patient population receiving this treatment is growing, in seniority and co-morbidity. There is little evidence regarding the safety of Botox injections in patients on anticoagulant/antiplatelet medication, the cessation of which may predispose to thromboembolic or ischaemic events. We have reviewed the number significant bleeding events after intravesical Botox injection in patients with concurrent anticoagulant/antiplatelet (AC/AP) use.METHODS:A retrospective review of all patients having Botox in 3 hospitals was conducted. Patients having Botox injections between January 2016 and July 2018, whilst on theraputic anticoagulant/antiplatelet medication were identified. Demographic data, indication for treatment, and bleeding requiring intervention were recorded.RESULTS:532 patients had intravesical Botox injections during this tim...